Every year a few people are affected by Duchenne muscular dystrophy and face a difficult future. Muscular tissue in their bodies is slowly degraded, leading to decreased mobility, respiratory problems, heart failure and premature death. Mathias Uhlén and Cristina Al-Khalili Szigyarto at KTH/SciLifeLab have now hopefully taken a step closer to development of new treatments for the disease.
Read full press release (in Swedish)
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.